Samuele Cazzamalli Selected Research

Samuele Cazzamalli Research Topics

Disease

30	Neoplasms (Cancer) 05/2024 - 12/2016
9	Renal Cell Carcinoma (Grawitz Tumor) 07/2023 - 12/2016
3	Prostatic Neoplasms (Prostate Cancer) 05/2024 - 01/2023
2	Hypoxia (Hypoxemia) 07/2023 - 10/2020
2	Necrosis 09/2021 - 01/2018
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 01/2018
2	Kidney Neoplasms (Kidney Cancer) 01/2017 - 12/2016
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2021
1	Arthritis (Polyarthritis) 01/2021
1	Carcinoma (Carcinomatosis) 01/2017

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 05/2024 - 01/2018
14	LigandsIBA 05/2024 - 12/2016
12	AntigensIBA 05/2024 - 01/2017
9	Carbonic Anhydrase IXIBA 07/2023 - 12/2016
7	CytokinesIBA 12/2023 - 11/2019
5	Immunoconjugates (Immunoconjugate)IBA 02/2024 - 01/2017
5	Acetazolamide (Diamox)FDA LinkGeneric 10/2020 - 12/2016
4	Interleukin-2 (IL2)IBA 04/2024 - 01/2018
4	Fibronectins (Fibronectin)IBA 09/2021 - 02/2019
4	monomethyl auristatin EIBA 01/2021 - 01/2017
3	Chimeric Antigen ReceptorsIBA 11/2021 - 01/2020
3	Fluorescein (Funduscein)FDA LinkGeneric 11/2021 - 01/2020
3	Interleukin-12 (IL 12)IBA 01/2021 - 02/2019
3	AntibodiesIBA 10/2020 - 01/2017
3	DipeptidesIBA 01/2017 - 12/2016
2	DNA (Deoxyribonucleic Acid)IBA 05/2024 - 07/2023
2	Monoclonal AntibodiesIBA 05/2024 - 10/2017
2	Small Molecule LibrariesIBA 05/2024 - 07/2023
2	glycylproline (Gly-Pro)IBA 01/2023 - 12/2022
2	serum P-component (CIt)IBA 01/2023 - 01/2017
2	Immunoglobulin G (IgG)IBA 01/2023 - 02/2019
2	Peptides (Polypeptides)IBA 01/2023 - 02/2019
2	Cytotoxins (Cytolysins)IBA 12/2022 - 01/2017
2	Radioisotopes (Radionuclides)IBA 01/2022 - 10/2020
2	AcidsIBA 02/2019 - 01/2018
2	cryptophycinIBA 12/2018 - 11/2018
1	Complement System Proteins (Complement)IBA 04/2024
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 02/2024
1	Proline (L-Proline)FDA Link 02/2024
1	exatecan (DX 8951f)IBA 02/2024
1	Peptide Hydrolases (Proteases)FDA Link 01/2023
1	4-azidobenzylcarazolol (pABC)IBA 01/2023
1	resiquimodIBA 01/2023
1	ProdrugsIBA 12/2022
1	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 08/2022
1	RadiopharmaceuticalsIBA 08/2022
1	MetalsIBA 01/2022
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2022
1	Surface Antigens (Surface Antigen)IBA 11/2021
1	placental alkaline phosphataseIBA 11/2021
1	A-Form DNA (A-DNA)IBA 11/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2021
1	F8 monoclonal antibodyIBA 01/2021
1	CollagenIBA 01/2021
1	Single-Chain AntibodiesIBA 01/2021
1	Interleukin-9 (Interleukin 9)IBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	Immunoglobulin FragmentsIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Amino Acids FDA Link 02/2019
1	Serum AlbuminIBA 01/2018
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2018
1	Horseradish PeroxidaseIBA 01/2018
1	Glycoproteins (Glycoprotein)IBA 01/2018
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2018
1	human TNKS proteinIBA 01/2018
1	SulfonamidesIBA 01/2017
1	EnzymesIBA 01/2017
1	Sunitinib (Sutent)FDA Link 01/2017
1	Antineoplastic Agents (Antineoplastics)IBA 01/2017
1	Sorafenib (BAY 43-9006)FDA Link 01/2017
1	3'- deamino- 3'',4'- anhydro- (2''- methoxy- 3''- oxy- 4''- morpholinyl)doxorubicinIBA 12/2016
1	Chelating AgentsIBA 12/2016

Therapy/Procedure

10	Therapeutics 04/2024 - 01/2017
3	Castration 05/2024 - 01/2023
2	Intravenous Injections 01/2021 - 01/2017
2	Immunotherapy 01/2021 - 11/2019
2	Drug Therapy (Chemotherapy) 01/2018 - 10/2017
1	Intravenous Administration 01/2021